Crossmark

Combination of GLP-1 receptor agonists and SGLT2 inhibitors in cardiometabolic disease: synergistic, additive, or non-additive effects? A narrative review

Crossref DOI link: https://doi.org/10.1186/s12933-026-03239-4

Published Online: 2026-06-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stamouli, Eirini

Trakatelli, Christina-Maria

Sarigianni, Maria

Kitsios, Konstantinos

Kotsis, Vasilis
License Information

Text and Data Mining valid from 2026-06-07

Accepted Manuscript valid from 2026-06-07
More Information

Article History

Received: 28 March 2026

Accepted: 22 May 2026

First Online: 7 June 2026

Declarations

:

: Not applicable

: The authors declare no competing interests.

Document is current

Any future updates will be listed below